우주 기반 바이오의약품 시장 보고서(2025년)

Space-based biopharmaceuticals are drugs and biologics that are developed or produced in the unique conditions of space, especially microgravity. These conditions can improve processes such as protein crystallization and drug stability. The goal is to use space's environment to create more effective treatments and innovative compounds that may not be possible to develop on Earth.

The primary categories of space-based biopharmaceuticals include vaccines, therapeutics, diagnostics, and other related products. Research conducted in space helps create vaccines that are more stable and effective by utilizing microgravity to improve antigen stability, protein crystallization, and immune response modeling. These products are applied in areas such as cancer treatment, infectious diseases, genetic disorders, and various other health conditions. The main users of these products include pharmaceutical companies, research organizations, healthcare providers, and additional stakeholders.

The space-based biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides space-based biopharmaceuticals market statistics, including the space-based biopharmaceuticals industry global market size, regional shares, competitors with the space-based biopharmaceuticals market share, detailed space-based biopharmaceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the space-based biopharmaceuticals industry. This space-based biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The space-based biopharmaceuticals market size has grown rapidly in recent years. It will grow from $4.29 billion in 2024 to $4.80 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth observed during the historic period can be credited to the rising demand for high-quality biopharmaceuticals, the emergence of private companies in the space sector, increased financial investment in space missions, the development and functionality of space stations, and the expansion of space-based manufacturing.

The space-based biopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $7.46 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period is expected to be driven by the expansion of the commercial space industry, the rise of space tourism, the aging global population, the growing demand for personalized medicine, and increased investment in space research. Key trends for the forecast period include remote biologics manufacturing, AI-driven experiment design, integration of telemedicine with space research, miniaturization of analytical devices, and the development of automated space lab platforms.

The increasing demand for advanced therapeutics is expected to drive the growth of the space-based biopharmaceuticals market. These next-generation treatments, including gene therapy, cell therapy, and biologics, aim to target diseases at the molecular or cellular level. The rising demand is fueled by the growing prevalence of complex and chronic conditions such as cancer, genetic disorders, and autoimmune diseases, which require more personalized, targeted, and effective therapies than traditional methods offer. Space-based biopharmaceuticals help meet this demand by using the unique environment of microgravity to improve drug efficacy and speed up the production of complex biologics. For example, in December 2023, the Advanced Therapy Treatment Centre in the UK reported a 31% increase in investment in advanced therapies between 2021 and 2022. This trend demonstrates how the growing demand for advanced therapeutics is driving the expansion of the space-based biopharmaceuticals market.

Companies in the space-based biopharmaceuticals market are increasingly forming strategic alliances to integrate cutting-edge technology. These collaborations focus on providing advanced biopharma and manufacturing facilities for the LIFE Pathfinder module, which are designed to meet the rigorous standards of biopharmaceutical research and production. For example, in August 2023, Sierra Space, a US-based commercial space company, partnered with Redwire Corporation to develop commercial pharmaceutical and biotech research capabilities in low-Earth orbit (LEO). This partnership also involves providing advanced biotechnology and manufacturing technologies to be incorporated into Sierra Space's LIFE habitat platform. The technologies include equipment for large molecule crystallization, industrial crystal manufacturing, and gradient-temperature furnaces, all aimed at supporting pharmaceutical drug development and human health research in microgravity.

In March 2025, Sierra Space joined forces with Yuri, a Germany-based space biotech company specializing in microgravity research and bioreactor technology. The goal of this partnership is to accelerate medical and biological research in space, facilitating innovative drug discovery and the development of advanced therapeutic solutions for diseases on Earth.

Major players in the space-based biopharmaceuticals market are Merck & Co. Inc., Bristol-Myers Squibb Company, Sierra Space Corporation, Rocket Lab USA Inc., Redwire Corporation, Axiom Space Inc., Varda Space Industries Inc., Nanoracks LLC, ResearchSat Pty Ltd., Techshot Inc., Space Tango Inc., nScrypt Inc., SpacePharma SA, Space Forge Ltd., LambdaVision Inc., Kibo Biotech Platform, ISS National Lab, BioServe Space Technologies, Space LiinTech, BioOrbit.

North America was the largest region in the space-based biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in space-based biopharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the space-based biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The space-based biopharmaceuticals market consists of revenues earned by entities by providing services such as microgravity research, in-space manufacturing, ISS utilization, and biocrystal optimization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The space-based biopharmaceuticals market also consists of sales of products including protein crystals for drug development, artificial retinas, stem cell-based therapies, and drug delivery systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Space-Based Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on space-based biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for space-based biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The space-based biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Vaccines; Therapeutics; Diagnostics; Other Product Types
• 2) By Application: Cancer Treatment; Infectious Diseases; Genetic Disorders; Other Applications
• 3) By End-User: Pharmaceutical Companies; Research Institutes; Healthcare Providers; Other End Users
• Subsegment:
• 1) By Vaccines: Infectious Disease Vaccines; Cancer Vaccines; RNA-Based Vaccines; Therapeutic Vaccines; Preventive Vaccines
• 2) By Therapeutics: Monoclonal Antibodies; Gene Therapies; Cell Therapies; Protein-Based Therapies; Peptide-Based Therapies
• 3) By Diagnostics: Molecular Diagnostics; Immunoassays; Point-of-Care Diagnostics; Biomarker Discovery; In Vitro Diagnostics
• 4) By Other Product Types: Regenerative Medicines; Biologics; Tissue Engineering Products; Bio-Chemical Reagents; Laboratory Consumables for Space Research
• Companies Mentioned: Merck & Co. Inc.; Bristol-Myers Squibb Company; Sierra Space Corporation; Rocket Lab USA Inc.; Redwire Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Space-Based Biopharmaceuticals Market Characteristics

3. Space-Based Biopharmaceuticals Market Trends And Strategies

4. Space-Based Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Space-Based Biopharmaceuticals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Space-Based Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Space-Based Biopharmaceuticals Market Growth Rate Analysis
• 5.4. Global Space-Based Biopharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Space-Based Biopharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Space-Based Biopharmaceuticals Total Addressable Market (TAM)

6. Space-Based Biopharmaceuticals Market Segmentation

• 6.1. Global Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Therapeutics
• Diagnostics
• Other Product Types
• 6.2. Global Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Treatment
• Infectious Diseases
• Genetic Disorders
• Other Applications
• 6.3. Global Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Research Institutes
• Healthcare Providers
• Other End Users
• 6.4. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Vaccines
• Cancer Vaccines
• RNA-Based Vaccines
• Therapeutic Vaccines
• Preventive Vaccines
• 6.5. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Gene Therapies
• Cell Therapies
• Protein-Based Therapies
• Peptide-Based Therapies
• 6.6. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunoassays
• Point-of-Care Diagnostics
• Biomarker Discovery
• In Vitro Diagnostics
• 6.7. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regenerative Medicines
• Biologics
• Tissue Engineering Products
• Bio-Chemical Reagents
• Laboratory Consumables for Space Research

7. Space-Based Biopharmaceuticals Market Regional And Country Analysis

• 7.1. Global Space-Based Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Space-Based Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Space-Based Biopharmaceuticals Market

• 8.1. Asia-Pacific Space-Based Biopharmaceuticals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Space-Based Biopharmaceuticals Market

• 9.1. China Space-Based Biopharmaceuticals Market Overview
• 9.2. China Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Space-Based Biopharmaceuticals Market

• 10.1. India Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Space-Based Biopharmaceuticals Market

• 11.1. Japan Space-Based Biopharmaceuticals Market Overview
• 11.2. Japan Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Space-Based Biopharmaceuticals Market

• 12.1. Australia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Space-Based Biopharmaceuticals Market

• 13.1. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Space-Based Biopharmaceuticals Market

• 14.1. South Korea Space-Based Biopharmaceuticals Market Overview
• 14.2. South Korea Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Space-Based Biopharmaceuticals Market

• 15.1. Western Europe Space-Based Biopharmaceuticals Market Overview
• 15.2. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Space-Based Biopharmaceuticals Market

• 16.1. UK Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Space-Based Biopharmaceuticals Market

• 17.1. Germany Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Space-Based Biopharmaceuticals Market

• 18.1. France Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Space-Based Biopharmaceuticals Market

• 19.1. Italy Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Space-Based Biopharmaceuticals Market

• 20.1. Spain Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Space-Based Biopharmaceuticals Market

• 21.1. Eastern Europe Space-Based Biopharmaceuticals Market Overview
• 21.2. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Space-Based Biopharmaceuticals Market

• 22.1. Russia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Space-Based Biopharmaceuticals Market

• 23.1. North America Space-Based Biopharmaceuticals Market Overview
• 23.2. North America Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Space-Based Biopharmaceuticals Market

• 24.1. USA Space-Based Biopharmaceuticals Market Overview
• 24.2. USA Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Space-Based Biopharmaceuticals Market

• 25.1. Canada Space-Based Biopharmaceuticals Market Overview
• 25.2. Canada Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Space-Based Biopharmaceuticals Market

• 26.1. South America Space-Based Biopharmaceuticals Market Overview
• 26.2. South America Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Space-Based Biopharmaceuticals Market

• 27.1. Brazil Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Space-Based Biopharmaceuticals Market

• 28.1. Middle East Space-Based Biopharmaceuticals Market Overview
• 28.2. Middle East Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Space-Based Biopharmaceuticals Market

• 29.1. Africa Space-Based Biopharmaceuticals Market Overview
• 29.2. Africa Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Space-Based Biopharmaceuticals Market Competitive Landscape And Company Profiles

• 30.1. Space-Based Biopharmaceuticals Market Competitive Landscape
• 30.2. Space-Based Biopharmaceuticals Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sierra Space Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Rocket Lab USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Redwire Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Space-Based Biopharmaceuticals Market Other Major And Innovative Companies

• 31.1. Axiom Space Inc.
• 31.2. Varda Space Industries Inc.
• 31.3. Nanoracks LLC
• 31.4. ResearchSat Pty Ltd.
• 31.5. Techshot Inc.
• 31.6. Space Tango Inc.
• 31.7. nScrypt Inc.
• 31.8. SpacePharma SA
• 31.9. Space Forge Ltd.
• 31.10. LambdaVision Inc.
• 31.11. Kibo Biotech Platform
• 31.12. ISS National Lab
• 31.13. BioServe Space Technologies
• 31.14. Space LiinTech
• 31.15. BioOrbit

32. Global Space-Based Biopharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Space-Based Biopharmaceuticals Market

34. Recent Developments In The Space-Based Biopharmaceuticals Market

35. Space-Based Biopharmaceuticals Market High Potential Countries, Segments and Strategies

• 35.1 Space-Based Biopharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Space-Based Biopharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Space-Based Biopharmaceuticals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer